؉ and Cl ؊ -coupled glycine transporters control the availability of glycine neurotransmitter in the synaptic cleft of inhibitory glycinergic pathways. In this report, we have investigated the involvement of the second intracellular loop of the neuronal glycine transporter 2 (GLYT2) on the protein conformational equilibrium and the regulation by 4␣-phorbol 12 myristate 13-acetate (PMA). By substituting several charged (Lys-415, Lys-418, and Lys-422) and polar (Thr-419 and Ser-420) residues for different amino acids and monitoring plasma membrane expression and kinetic behavior, we found that residue Lys-422 is crucial for glycine transport. The introduction of a negative charge in 422, and to a lower extent in neighboring N-terminal residues, dramatically increases transporter voltage dependence as assessed by response to high potassium depolarizing conditions. In addition, [2-(trimethylammonium)ethyl] methanethiosulfonate accessibility revealed a conformational connection between Lys-422 and the glycine binding/permeation site. Finally, we show that the mutation of positions Thr-419, Ser-420, and mainly Lys-422 to acidic residues abolishes the PMA-induced inhibition of transport activity and the plasma membrane transporter internalization. Our results establish a new structural basis for the action of PMA on GLYT2 and suggest a complex nature of the PMA action on this glycine transporter.
Na
؉ and Cl ؊ -coupled glycine transporters control the availability of glycine neurotransmitter in the synaptic cleft of inhibitory glycinergic pathways. In this report, we have investigated the involvement of the second intracellular loop of the neuronal glycine transporter 2 (GLYT2) on the protein conformational equilibrium and the regulation by 4␣-phorbol 12 myristate 13-acetate (PMA). By substituting several charged (Lys-415, Lys-418, and Lys-422) and polar (Thr-419 and Ser-420) residues for different amino acids and monitoring plasma membrane expression and kinetic behavior, we found that residue Lys-422 is crucial for glycine transport. The introduction of a negative charge in 422, and to a lower extent in neighboring N-terminal residues, dramatically increases transporter voltage dependence as assessed by response to high potassium depolarizing conditions. In addition, [2-(trimethylammonium)ethyl] methanethiosulfonate accessibility revealed a conformational connection between Lys-422 and the glycine binding/permeation site. Finally, we show that the mutation of positions Thr-419, Ser-420, and mainly Lys-422 to acidic residues abolishes the PMA-induced inhibition of transport activity and the plasma membrane transporter internalization. Our results establish a new structural basis for the action of PMA on GLYT2 and suggest a complex nature of the PMA action on this glycine transporter.
The inhibitory action of glycine neurotransmitter in spinal cord and brain stem of vertebrates is terminated by re-uptake through sodium-driven plasma membrane glycine transporters (1, 2) . At the glycinergic pathways, involved in movement, vision, and audition, the neuronal isoform GLYT2, 1 together with the mainly glial GLYT1, control the availability of the transmitter in the synaptic cleft (3) . The deletion of the glycine transporter genes results in postnatal lethal phenotypes caused by overinhibition, GLYT1 (4), or hyperekplexia, GLYT2 (5) , which uncovers the different functions of these transporters. GLYT2 exhibits functional properties characteristic of a phasic neuronal physiological role, and its modulation may find applications in the treatment of neuromotor deficiencies (6 -11) .
The proposed structure for GLYT2, shared by the Na ϩ -and Cl Ϫ -dependent neurotransmitter transporters, contains 12 transmembrane segments (TM) connected by alternating extracellular (EL) and intracellular (IL) hydrophilic loops and terminal ends lying in the cytoplasm (12) (13) (14) (15) . Although little is known about the three-dimensional structure of these transporters (16) , site-directed mutagenesis approaches have permitted the identification of critical residues for the transport function in TMI, -III, and -IV (17) (18) (19) (20) (21) (22) , which are candidates to contribute to the binding of substrates. In addition, conformationally active residues have been identified in several hydrophilic loops (23) (24) (25) (26) (27) (28) (29) (30) , and it has been suggested that IL2-IL3-IL4 might be part of an intracellular "gating" domain, because a mutation of three residues in those loops of DAT seems to disrupt intramolecular interactions stabilizing the conformation able to bind extracellular substrate (31) (32) (33) .
The Na ϩ -and Cl Ϫ -dependent neurotransmitter transporters are believed to be tightly regulated, making the protein kinase C (PKC)-mediated regulation the most studied mechanism (34, 35) . Activation of PKC by phorbol esters such as 4␣-phorbol 12-myristate 13-acetate (PMA), leads to acute reduction in transport activity of the monoamine transporters, the ␥-aminobutyric acid transporter GAT-1 and GLYT1 (35) . This downregulation of the transport activity seems to be due to a PMAinduced internalization of the plasma membrane residing transporters (36, 37) , although no correlation between internalization and PKC-induced phosphorylation has been established for the DAT (37) . Consequently, no individual consensus phosphorylation site for PKC has been proven to be responsible for the PMA-induced internalization (37, 38) .
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EXPERIMENTAL PROCEDURES

Materials-[2-
3 H]Glycine (1.6 TBq/mmol) was from PerkinElmer Life Sciences. Ligase and restriction enzymes were from Roche Applied Science. Peroxidase-linked anti-rabbit IgG and ECL reagent were from Amersham Biosciences. NHS-SS-biotin was obtained from Pierce. MT-SET and MTSEA-biotin were obtained from Toronto Research Chemicals Inc. (Toronto, Canada). Anti-GLYT2 antibody against the N-terminal region of the recombinant protein was characterized previously (6) . All other reagents were obtained in the purest form available.
Site-directed Mutagenesis-GLYT2 substitution mutants were created by site-directed mutagenesis using the method of Higuchi as described previously (10) . The mutated region was subcloned downstream from the cytomegalovirus promoter of the pcDNA3 mammalian expression vector (Invitrogen), containing the wild type GLYT2a cDNA (12) , by using flanking restriction sites. All mutations were confirmed by DNA sequencing. For the relevant mutants at least two independent Escherichia coli colonies carrying the mutant plasmids were characterized by sequencing and transport activity.
Cell Growth and Protein Expression-COS 7 cells (American Type Culture Collection) were grown at 37°C and 5% CO 2 in high glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Transient expression in COS 7 cells was carried out using LipofectAMINE Plus (Invitrogen) following the procedure indicated by the supplier. Cells were incubated for 48 h at 37°C and then used for modification and/or transport assays.
Glycine Transport Assay-Transport assays were performed at 37°C on COS 7 cells 48 h after transfection in HEPES-buffered saline (HBS: 150 mM NaCl, 10 mM HEPES-Tris, pH 7.4, 1 mM Ca 2 Cl, 5 mM KCl, 1 mM MgSO 4 , 10 mM glucose) as described previously (10) . Cells were incubated for the indicated times in 0.25 ml of an uptake solution containing 2 Ci/ml 3 H-labeled glycine isotopically diluted to yield 10 M final glycine concentration in HBS or the medium indicated in the figure legends. Kinetics for glycine were performed by varying glycine concentrations from 1 to 1000 M. For the experiments where Na ϩ or Cl Ϫ had to be isotonically replaced, choline chloride or sodium gluconate was used to obtain the desired Na ϩ or Cl Ϫ concentrations. In all the experiments the glycine transport was measured by subtracting the glycine accumulation by mock-transfected cells from that of the transporter cDNA transfected cells. The background transport of glycine was usually 0.3 nmol of glycine/mg of protein/6 min, which represented around the 20% of the glycine transport by wild type GLYT2. Protein concentration was determined by the method of Bradford.
Treatment with PKC Activators or Inhibitors-Transfected or mocktransfected COS cells expressing the indicated transporters were incubated for 1 h at 37°C with PMA (20 nM to 1 M) or 1 M PMA plus 1 M staurosporine or vehicle (Me 2 SO). Cells were then washed, and glycine transport activity was assayed as described.
Sulfhydryl Modification by MTSET-The day before the experiment, transfected or mock-transfected COS 7 cells were plated at 30% confluence (72,000 cells per well) on polylysine-covered 24-well plates. The next day, cells were washed at room temperature with 1 ml of HBS solution or HBS in which LiAc isotonically replaced NaCl. In protection experiments, protecting agents were added to this solution. After washing, each well was preincubated at room temperature with 300 l of the former medium containing the indicated concentrations of the MTSET reagent. Following 10 min of incubation, the medium was removed, and the cells were washed once with 1 ml of the same solution, at least twice with 1 ml of HBS, and then immediately assayed for [ 3 H]glycine transport as described above. MTSET was dissolved in water as a 100ϫ stock solution that was always freshly prepared immediately prior to use.
Labeling with MTSEA-biotin and Sulfo-NHS-SS-biotin-COS 7 cells were grown in 12-well plates and transfected as described above. 48 h after transfection, cells were washed twice with 1.0 ml per well of HBS containing NaCl (or LiAc when indicated). In protection experiments, protecting agents were added to this solution. This was followed by 10 min of incubation with the indicated concentration of MTSEA-biotin (2 mM stock solution, dissolved in water immediately before use) or 40 min of incubation with sulfo-NHS-SS-biotin (1.5 mg/ml, Pierce) in total surface expression determinations. After washing three times with 1 ml of the same solution (supplemented with 100 mM lysine in total surface expression determinations), cells were scraped in 0.6 ml of 50 mM Tris, pH 7.5, 150 mM NaCl, 0.4 mM phenylmethylsulfonyl fluoride, and 0.004 mM pepstatin, and the protein concentration was determined by the method of Bradford. Cells were lysed (equal amounts of total proteins from each well) using SDS-lysis solution (50 mM Tris pH 7.5, 150 mM NaCl, 0.4 mM phenylmethylsulfonyl fluoride, 0.004 mM pepstatin, 5 mM EDTA, 1% Triton X-100, 1% SDS, and 0.25% sodium deoxycholate) for 30 min on ice. In total surface labeling with sulfo-NHS-SS-biotin, biotinylated proteins were recovered by overnight incubation with 40 l of streptavidin-agarose beads/sample (Sigma) at 4°C in an end-over-end shaker. Proteins bound to the beads were eluted with 70 l of SDS-PAGE sample buffer (40 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 0.1 M dithiothreitol (DTT), 0.01% bromphenol blue) for 10 min at 80°C. Aliquots of each sample were run on a 7.5% SDS-PAGE gel and transferred onto nitrocellulose for Western blotting (6) . Bands were visualized with the ECL detection method and quantified on a GS-710 Calibrated Imaging Densitometer from Bio-Rad with Quantity One software by using film exposures that were in the linear range. Standard errors in biotinylation studies were calculated after densitometry from at least three separate experiments. MTSEA-biotinylated samples were compared with NHS-SS-biotinylated samples (39) .
Immunofluorescence and Confocal Microscopy-Control or transfected COS 7 cells growing in 24-well plates at 48 h after transfection were subjected to immunofluorescence using a primary antibody against the N terminus of GLYT2 and a goat anti-rabbit secondary antibody coupled to Alexa 488 fluorophore as described (10) . Cells were visualized on a Confocal Microradiance (Bio-Rad) coupled to a vertical Axioskop2 microscope (Zeiss).
Data Analysis-Non-linear or linear regression fits of experimental data were performed with ORIGIN (Microcal Software, Northampton, MA). The effect of MTSET on uptake is expressed as the fraction of uptake remaining (F ϭ 100 ϫ uptake after/uptake before). To calculate second order apparent rate constants for MTSET inhibition (k), F was plotted as a function of MTSET concentration in M, and the data were fitted to a first order exponential decay equation (F ϭ F min ϩ F max ϫ e exp(Ϫk ct )). The resulting first order apparent rate constant divided by the incubation time in seconds was taken as a measurement of the second order rate constant (23) . Statistical analysis was performed on transport data from at least three experiments.
RESULTS
To test whether the intracellular loop conserved sequence of GLYT2 plays a role in transporter function, we introduced several point mutations at each of the three lysines of IL2, and the mutated transporters were assayed for glycine transport after expression in COS cells. As shown in Table I , no major alterations in the kinetic parameters for glycine, chloride, and sodium were observed for the mutants, although the substitution of Lys-418 and Lys-422 for arginine or neutral residues increased the V max for glycine without affecting the apparent affinity for the cosubstrates. However, mutant K422E showed an intriguing alteration of all the measured parameters with reduced V max and K m values for glycine and decreased apparent affinities for chloride and sodium. Because the observed differences in V max between GLYT2 wild type and the mutated transporters could be the result of different surface expression levels, we performed cell surface biotinylation followed by Western blot (Fig. 1 ). Mutants K418R, K418A, K422R, and K422Q were indeed delivered more efficiently to the plasma membrane than the wild type, which accounts for the observed increases in V max . However, although K422E showed lower surface levels (ϳ50% of wild type), its V max value was much lower (about 25%, see Table I ), indicating that glycine transport is somehow less efficient in this mutant.
The kinetic behavior of K422E with inefficient glycine transport and lower apparent affinities for Na ϩ and Cl Ϫ could be compatible with an alteration in the mutant affecting the permeation pathway. We hypothesized that if Lys-422 were lying in the inner part of the permeation pathway, perhaps its substitution for an acidic residue could make IL2 accessible from the outside. Therefore, we decided to study the accessibility of exogenous cysteine residues inserted in this region, and for this purpose we initially took the cysteine mutants of the three lysines Lys-415, Lys-418, and Lys-422, expressed them in COS cells, and assayed MTSET sensitivity ( Fig. 2A) . We observed that if the incubation with the reagent was performed in HBS containing lithium acetate instead of NaCl, the mutant K422C was inhibited around 30% by 5 mM MTSET (p Ͻ 0.01 in Student's t test). Most surprising, if the MTSET treatment was applied to all the IL2 mutants, not only was mutant K422C inhibited in lithium acetate but also the mutants to glutamate of the three lysines (K415E, K418E, and K422E), being maximal at the inhibition of K422E (about 40% at 5 mM MTSET, p Ͻ 0.01 in Student's t test). Curiously, this inhibition by MTSET could not be reversed by DTT or any other reducing agent (Fig.  2B ), indicating that it was not due to MTSET reaction with SH groups of the transporters. Consequently, there was no cysteine labeling with MTSEA-biotin ( Fig. 2C ), suggesting that IL2 is not accessible from the outside.
Because the observed inhibition by MTSET was only produced in media containing acetate or propionate (not shown), we tested the effect of these compounds in the transport of glycine by K422E. Most interesting, if the glycine transport assay was performed in the presence of increasing acetate concentrations and a fixed concentration of chloride, mutant K422E, but not GLYT2 wild type, became progressively activated (Fig. 3, A and B) , and this activation disappeared in the presence of 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS), a blocker of the Cl Ϫ fluxes through the plasma membrane (Fig. 3A) or in the presence of ouabain, an inhibitor of the Na ϩ /K ϩ -ATPase (Fig. 3B) . Because acetate and propionate are the conjugated bases of weak acids, which can cross the plasma membrane in their protonated form and cause a decrease in intracellular pH, triggering compensatory mechanisms in the cell (40) , these results suggest that K422E is more sensitive than the wild type to the effects of weak acids on the membrane potential. In fact, the direct depolarization of the plasma membrane with high potassium selectively inhibits K422E, thus confirming the higher voltage dependence of this mutant (Fig.  3C) . We then performed glycine transport assays in the conditions shown in Fig. 3C for all the IL2 mutants (Table II) , and we observed that for the mutants to glutamate, the negative slopes of the resulting plots (activity versus increasing K ϩ concentration) were progressively enhanced from position 415 to 422, and within position 422, the slopes increased as long as the substituting residue became more acidic. These results suggest that the involvement in voltage dependence increases from position 415 to 422 and the voltage dependence is higher in mutants where a negative charge is introduced.
FIG. 3.
A and B, effect of increasing acetate concentrations on glycine transport by wild type GLYT2 and K422E. COS 7 cells transiently expressing the wild type GLYT2 or K422E mutant were assayed for glycine uptake for 6 min in HBS where the NaCl concentration was kept at 50 mM and the concentrations of sodium acetate and sodium gluconate were varied from 0 to 100 and 100 to 0 mM, respectively, in the absence or presence of 1 mM DIDS (A) or 1 mM ouabain (B). Data are presented as percent activity of the 0 mM acetate point which were 1.42 Ϯ 0.6 and 0.65 Ϯ 0.3 nmol glycine/mg protein/6 min for GLYT2 and K422E, respectively. Experimental data were fitted by linear regression analysis. Thick line, GLYT2; thin line, K422E; solid lines, no addition; dotted lines, DIDS (A) or ouabain (B). A representative experiment is shown that was repeated four times. Bars represent S.E. of triplicate determinations. C, effect of increasing potassium concentrations on glycine transport by wild type GLYT2 and K422E. Experimental conditions were identical to A and B, but the NaCl concentration in HBS was kept at 100 mM NaCl, and the concentrations of KCl and choline chloride were varied from 0 to 50 and 50 to 0 mM, respectively, in the absence or presence of 1 mM DIDS. 100% values were 1.56 Ϯ 0.5 and 0.73 Ϯ 0.2 nmol glycine/mg protein/6 min for GLYT2 and K422E, respectively. Experimental data were fitted by linear regression analysis. Thick line, GLYT2; thin line, K422E; solid lines, no addition; dotted lines, DIDS. A representative experiment is shown which was repeated six times. Bars represent S.E. of triplicate determinations. One possible explanation of the K422E phenotype, according to its kinetic behavior and its higher voltage dependence, would be the locking of the transporter in a conformational state that displays the cosubstrate-binding sites to the inside (''inward conformation'') (28) . During the course of this work, Loland et al. (31) proposed that the equivalent residue to Lys-422 in DAT (Lys-264) might form part of a conformationally active intracellular gating domain that might control access of the substrate to the intracellular milieu (31) . If this hypothesis were correct also for GLYT2, residues that show alternating access and are extracellularly accessible in the outward-facing conformation would become occluded in the K422E background. Thus, we chose two residues that fulfilled those requisites: Ile-292 in TMIII (18 -20) and Ala-223 in EL1 (23), and we generated two cysteine point mutants, expressed them in COS cells, and assayed MTSET sensitivity (Fig. 4A) and MTSEAbiotin labeling (Fig. 4B) . The two point mutants were inhibited in NaCl by MTSET and labeled by MTSEA-biotin in a DTTreversible (not shown) and glycine-protected manner (Fig. 4) , reflecting their extracellular accessibility. As shown previously, this contrasts with the MTSEA-biotin-unlabeled and MTSET-resistant K422E (in NaCl). However, if the point mutations were introduced in K422E, thus generating two double mutants (I292C/K422E and A223C/K422E), the inhibition by MTSET was reduced from 57 (I292C) to 29% (I292C/K422E) at 0.5 mM MTSET (p Ͻ 0.01 in Student's t test) and from 61 (A223C) to 30% (A223C/K422E) at 5 mM MTSET (p Ͻ 0.01 in Student's t test, Fig. 4A ). The apparent inhibition constants for MTSET inactivation were calculated from dose-response experiments (data not shown), and they were lower in the double mutants, although the reduction was more apparent in A223C versus A223C/K422E (k ϭ 3.1 Ϯ 0.4 and 1.5 Ϯ 0.1 M Ϫ1 s Ϫ1 , respectively) than in I292C versus I292C/K422E (k ϭ 2.4 Ϯ 0.3 and 1.6 Ϯ 0.2 M Ϫ1 s Ϫ1 , respectively). Accordingly, the MTSEAbiotin labeling was diminished by 95% in A223C/K422E and by 20% in I292C/K422E compared with their corresponding single mutants (Fig 4B) . This strongly suggests a reduced external accessibility of the introduced cysteines in the double mutants, and supports the idea that position 422 is conformationally connected with the glycine-binding site in such a way that its mutation blocks the external access to positions 292 and 223.
All the presented data suggest that Lys-422 might be a good candidate for a regulatory residue of GLYT2 activity. Because IL2 contains two residues in putative consensus sequences for PKC phosphorylation (Thr-419 and Ser-420), we decided to test how the activation of this kinase with PMA affected the activity of the IL2 mutants including three additionally constructed mutant transporters: T419E, S420E, and S420A. The transporters were expressed in COS cells and incubated with PMA, and glycine transport activity was assayed (Fig. 5A) . As expected, the activity of GLYT2 wild type was reduced by about 30% (29.6 Ϯ 6.2%, p Ͻ 0.01 in Student's t test) after 1 h of incubation with 1 M PMA at 37°C, which also happened with A223C and I292C mutants. This inhibition, reversed by the PKC inhibitor staurosporine, was slightly reduced in S420A (see also Table III) . By contrast, the PMA inhibition was diminished in T419E (13% inhibition), and there was no inhibition in S420E. Most interesting, K422E and the double mutants containing this mutation were not only uninhibited by PMA but were activated by the drug. The activation reached a similar level to that obtained in the presence of staurosporine (10 -30%). The PMA inhibition was not a result of nonspecific 4 . A, MTSET sensitivity of I292C, A223C, and the double mutants I292C/K422E and A223C/K422E. COS cells expressing the indicated single or double mutants were preincubated for 10 min without or with the concentration of MTSET that produced about 50% inhibition (0.5 mM for I292C mutants and 5 mM for A223C mutants) in HBS. After washing, uptake was measured in standard NaCl HBS medium, as described under ''Experimental Procedures.'' Data are presented as percent activity of the control in the absence of MTSET. 100% values were 1.51 Ϯ 0.4, 1.10 Ϯ 0.3, 0.86 Ϯ 0.3, 1.55 Ϯ 0.5, and 1.04 Ϯ 0.2 nmol glycine/mg protein/6 min for I292C, I292C/K422E, A223C, K422E, and A223C/K422E, respectively. Bars represent S.E. of at least three experiments done in triplicate. Asterisks indicate significant differences from the corresponding single mutant: *, p Ͻ 0.01 in Student's t test. B, MTSEA-biotin labeling of I292C, A223C, and the double mutants I292C/K422E and A223C/K422E. Experimental conditions are identical to Fig. 2C , but the MTSEA-biotin (0.5 mM) labeling was performed in HBS (NaCl) in the absence or presence of 5 mM glycine. The densitometric analysis of the 97-kDa bands was normalized by the total expression of the transporters. phorbol ester effects, because the inactive analog 4␣-phorbol 12,13-didecanoate did not produce GLYT2 down-regulation. Fig. 5B illustrates the effect of increasing PMA concentrations on the glycine transport activity by wild type GLYT2 and the four Lys-422 substitution mutants. PMA caused a dose-response inhibition of wild type GLYT2 and also of K422R, but the PMA response was reduced in K422Q and lost in K422C and K422E mutants, which were activated by the treatment.
To gain information on the nature of the PMA-induced inhibition of GLYT2, we performed kinetic measurements after treatment in the absence or presence of PMA for the IL2 relevant mutants (Table III) . As expected, the incubation with PMA caused reductions in V max values of about 50% in all the mutants except for the Glu and Cys substitution mutants where this reduction was lower (around 30% for T419E, S420E, and K422C and only 0 -5% for K422E). Most surprising, the K m values for glycine were also reduced around 50% for all the mutants with lower decreases in T419E and S420E. These results suggest that GLYT2 inhibition by PMA is a complex phenomenon, because reductions in V max values of related transporters have been associated with a decrease in the number of surface transporters, but a decrease in K m values suggests a change in the activity of the transporter molecules residing in the plasma membrane.
One possible action of PMA that might explain the observed results would be that the PMA treatment could alter the conformational state of the transporters. This possibility could help to explain the PMA-induced activation of K422E and the observed decrease in K m values after PMA treatment. To test this idea, we performed two kinds of experiments (Fig. 6) . First, we measured glycine transport in the presence of increasing K ϩ concentrations (conditions of Fig. 3C ) after 1 h of PMA treatment to test whether the voltage dependence of the mutants was altered by PMA incubation. As shown in Fig. 6A , the slopes of the curves remained nearly unchanged, suggesting that there is no alteration of T419E, S420E, and K422E voltage dependence by PMA. Second, we measured the sensitivity to MTSET of mutants A223C and A223C/K422E after 1 h of incubation with PMA or vehicle (Fig. 6B) , and again, the inhibition shown was not changed as a consequence of the PMA treatment, suggesting that the conformation of the transporters remained unvaried or transporters underwent an undetectable conformational change.
Because PMA treatment seems not to affect the conformational state of IL2 mutants, we wished to know whether the absence of activity down-regulation was due to a PMA failure to induce internalization of the plasma membrane-residing transporters. For this purpose, we performed cell surface biotinylation followed by Western blot after 1 h of treatment with increasing PMA concentrations (Fig. 7) . The plasma membrane expression of GLYT2 wild type was reduced at concentrations of PMA higher than 20 nM (80% of control at 1 M PMA treatment), although it was slightly enhanced at low PMA concentrations. The reduction in surface transporter at high PMA concentrations was not observed for T419E (not shown), S420E, and K422E where there was an increasing number of plasma membrane transporters as the PMA concentration was raised (25 and 50% increase at 200 nM and 1 M PMA, respectively). However, although in qualitative terms the amount of surface transporter runs parallel to the transport activity under identical PMA treatment conditions (see A223C in Fig. 6B ), the parallelism between the level of transport activity and the amount of plasma membrane transporters after the treatment was not quantitatively complete (compare Figs. 6B and 7B), suggesting that some other factors might be involved in GLYT2 inhibition by PMA. Indeed, we could not see any surface transporter reduction after 1 M PMA treatment during the 1 h in COS cells expressing GLYT2, S420E, or K422E when monitored by immunofluorescence of permeabilized cells with an antibody directed to the intracellular N-terminal end of GLYT2 (Fig. 8) . Instead, we observed a PMA-induced change in cell morphology in GLYT2-expressing cells that was less evident in cells expressing S420E or K422E. DISCUSSION We have focused our structure-function studies on the second intracellular loop of GLYT2, because this 8-amino acid hydrophilic region, connecting TMIV and V, contains an interesting accumulation of charged and polar residues, such as Lys-415, Lys-418, Thr-419, Ser-420, and Lys-422, very conserved among the Na ϩ -and Cl Ϫ -coupled neurotransmitter transporters with only one non-conservative substitution (K418Q) in the monoamine transporters. In the present study we show that Lys-422 of rat GLYT2 is a critical residue either for glycine transport, because it is conformationally connected to the substrate bind- ing/permeation site, for GLYT2 membrane expression, or for GLYT2 regulation because its substitution abolishes the PMAinduced inhibition of this glycine transporter.
Analysis of the multiple substitutions at selected positions of IL2 has shown an involvement of this loop in GLYT2 plasma membrane expression. The substitution of residues Lys-418 and Lys-422 with arginine or neutral residues enhances the amount of surface transporter, whereas the introduction of a negative residue in 415, 418, or 422 interferes with the normal delivery of the transporter to the plasma membrane. Consequently, double or triple mutants of the three IL2 lysines (K422E/K415E, K422E/K418E, and K422E/K415E/K418E) are not functional because they are not delivered to the plasma membrane (data not shown).
In addition, mutant K422E displays functional features similar to the substitutions of residues Lys-264 (equivalent to Lys-422), Asp-345 in IL3, and Asp-436 in IL4 of DAT, proposed as a part of a network of molecular interactions needed for conformational changes during the transport cycle (32, 33) . Three lines of evidence allow us to conclude that K422E transporter molecules are more prone to acquire the inward-facing conformation. First, its kinetic behavior, the reduced apparent affinities for Na ϩ and Cl Ϫ suggest that the transporter is poised away from the Na ϩ -and Cl Ϫ -bound conformation, and the low V max and K m values for glycine may reflect that, once the transporter binds the ions, it may readily bind and translocate glycine in order to return to the inward-facing conformation (28) . Second, a transporter that is oriented toward the 6 . A, effect of increasing potassium concentrations on glycine transport by wild type GLYT2, T419E, S420E, and K422E after PMA treatment. Cells expressing the indicated transporters were treated with 1 M PMA or vehicle for 1 h at 37°C and assayed for glycine transport in experimental conditions identical to Fig. 3C . 100% values were 1.56 Ϯ 0.5, 1.52 Ϯ 0.3, 1.68 Ϯ 0.6, and 0.62 Ϯ 0.3 nmol glycine/mg protein/6 min for GLYT2, T419E, S420E, and K422E, respectively. Experimental data were fitted by linear regression analysis. Thick line, GLYT2; thin lines, mutant transporters; solid lines, vehicle; dotted lines, PMA. A representative experiment is shown that was repeated at least three times. Bars represent S.E. of triplicate determinations. B, MTSET sensitivity of A223C and the double mutant A223C/K422E after incubation with increasing PMA concentrations. Cells expressing the indicated mutants were treated with vehicle or the indicated PMA concentrations for 1 h at 37°C and incubated with 5 mM MTSET in HBS. Data are presented as percent activity of the control in absence of MTSET. 100% values were 1.51 Ϯ 0.5 and 1.55 Ϯ 0.3 nmol glycine/mg protein/6 min for A223C and A223C/K422E, respectively. Bars represent S.E. of two determinations done in triplicate.
inward-facing empty state has been shown to display increased voltage dependence because the reorientation of the empty transporter becomes increasingly rate-limiting (28) . The higher voltage dependence of K422E has been revealed, in our hands, by MTSET inhibition of the mutant in media containing acetate or propionate. The reaction of MTSET with SH groups of plasma membrane proteins produces sulfinic acid that causes a local decrease in extracellular pH, thus increasing the proportion of weak acid-protonated form which passes freely across the cell membrane. Once inside, the weak acid partially dissociates causing a reduction in intracellular pH (41) . In the absence of Na ϩ and Cl Ϫ (conditions of the MTSET incubation in lithium acetate), the compensatory mechanisms necessary for pH homeostasis such as the Na ϩ /H ϩ exchanger or the rectifying Cl Ϫ currents or Cl Ϫ /anion fluxes cannot be triggered, leading to a plasma membrane depolarization with inhibitory consequences for K422E but not for GLYT2 (Fig. 2) . As shown later in glycine transport assays in the presence of acetate (Fig. 3) , DIDS-sensitive Cl Ϫ fluxes and ouabain-sensitive Na ϩ /K ϩ -ATPase activity are some of the compensatory mechanisms triggered in COS cells during an acetate load, although we also observed the involvement of acetazolamide-inhibited carbonic anhydrase activity and Na ϩ /H ϩ exchanger activity (data not shown).
The corroboration of K422E higher voltage dependence was performed by direct plasma membrane depolarization with high potassium concentration during the glycine transport assay (Figs. 3 and 6 ). Under these conditions, the mutant transporter is selectively inhibited, suggesting that the compensatory cellular mechanisms against this injury are sufficient to keep the membrane potential at a value that is tolerated by GLYT2 but not by K422E. We have used the high potassium depolarization assay as a method to monitor the relative proportion of transporter molecules that are inward-facing, taking into account that the inward-faced molecules confer the higher voltage dependence to the mutants. The positive correlation between the sensitivity to the membrane depolarization and the conformational state of the transporters has been assessed by MTSET accessibility experiments (Figs. 4 and 6) . From the high potassium depolarization assay, it has been determined that the introduction of a negative charge in IL2 enhances the voltage dependence of the mutants, and this effect progressively increases from positions 415 to 422 being maximal in this latter residue. This provides evidence that the percentage of inward-facing molecules in the glutamate mutants augments from the N-to C-terminal ends of IL2, revealing the higher relevance of position 422 in the assessment of the conformational state of GLYT2. Additionally, the proportion of mutant transporter molecules inwardly oriented increases as long as the positive charge at position 422 disappears and is replaced by a negative charge amino acid.
The third line of evidence of the K422E conformational state came from MTSET accessibility assays that have confirmed the existence of a conformational connection between IL2 and the substrate binding/permeation site of GLYT2 (Figs. 4 and 6) . The external accessibility of engineered cysteines in positions Ala-223 and Ile-292, which show alternating access and are extracellularly accessible in the outward-facing conformation (19, 23, 26) , becomes reduced in the background of IL2 inwardfaced mutants such as T419E, S420E, and mainly K422E. Most interesting, the external accessibility of I292C, as monitored by MTSEA-biotin labeling, was much lower that that of A223C, although its MTSET inactivation rate was higher (Fig. 4) . This points out that Ile-292 is a more critical residue for glycine transport than A223C, which is in agreement with our previous observations (20) . In addition, the reduction in MTSET accessibility from single (outward facing) to double (inward facing) mutants was lower for I292C than A223C mutants, according to the higher mobility of EL1 during the transport-associated conformational changes (23 lationship connecting IL2 residues and the substrate-binding site shows a gradient of intensity increasing from the N-to C-terminal end of the loop with minimum connection at position 415 and maximum connection at 422, which also points toward a higher relevance of Lys-422 within a series of possible regulatory residues in IL2.
Finally, we have demonstrated that the substitution of IL2 residues Thr-419, Ser-420, and Lys-422 can abolish the GLYT2 down-regulation induced by PMA. Mutants T419E, S420E, and K422E are resistant to the PMA-promoted inhibition of glycine transport activity by GLYT2. This PMA resistance also shows a differential response within IL2 residues. The response is maximal for K422E that is activated by PMA but is minimal for T419E, which shows a PMA-attenuated response slightly lower than that of wild type GLYT2 (Figs. 5 and 6 ). Although residues Thr-419 and Ser-420 fulfill the requisites of the consensus sequences for PKC phosphorylation, the fact that the PMA resistance induced by the substitution of these residues is lower than that induced by the substitution of residue Lys-422 suggests that the action of PMA is not mediated by direct phosphorylation of residues 419 and 420. This would be in agreement with previous observations made on GLYT1, where the substitution of all the consensus sequences for PKC phosphorylation by alanines showed no effect in PMA action (38) . In fact, Grånä s et al. (37) have observed no correlation between internalization and PKC-induced phosphorylation in the DAT.
The inhibition of GLYT2 transport activity by PMA seems to be a complex phenomenon. The fact that PMA inhibition reduces V max as well as K m values of glycine transport suggests that transporter internalization is not the only mechanism involved in PMA action on GLYT2. Although K m reductions after PMA treatment have been reported for other neurotransmitter transporters such as serotonin transporter (35, 42) , norepinephrine transporter (43) , and DAT (44), their magnitudes were lower than that observed in the present study, suggesting that PMA-induced changes in GLYT2 activity may occur. Moreover, although we observed a decrease in the biotinylated plasma membrane-residing transporters after (200 nM to 1 M) PMA treatment in GLYT2 and not in PMA-resistant mutants (S420E and K422E), this decrease seems to be lower than the reduction in transport activity observed in PMA treated GLYT2. Besides, the decrease is not seen by confocal microscopy after immunofluorescence (Fig. 8) . Although the PMA-induced transporter internalization is the most accepted mechanism to explain the PMA inhibition of Na ϩ and Cl Ϫ -coupled neurotransmitter transporters, other mechanisms have been proposed (35) . From our data, a nonspecific phorbol ester effect affecting the plasma membrane potential (45) can be discarded because the inactive analog 4␣-phorbol 12,13-didecanoate did not produce GLYT2 down-regulation, and the effect is reversed by staurosporine. In addition, the inhibition of transport activity through PMA-induced interaction with syntaxin 1A, which has been proven for GAT1 (46) and could be possible for GLYT2 (47) , seems not to take place in COS cells (46, 48) . However, Sakai et al. (48) proposed the involvement of the actin cytoskeleton in the mechanism of PMA action on serotonin transporter in COS cells. By using confocal laserscanning fluorescence, they observed PMA-induced morphological changes, very similar to the ones observed in this study, which made them suggest that the activation of PKC affected transport activity indirectly through a hypothetical interaction transporter-actin cytoskeleton. It seems reasonable to suggest that such transporter-actin cytoskeleton interactions might also be involved in GLYT2 inhibition by PMA.
According to the above exposed considerations, we can propose the following hypothesis for the explanation of the PMA resistance of IL2 mutants: GLYT2 membrane expression is the result of a dynamic equilibrium between its membrane delivery and its internalization. GLYT2 could be bound to a regulatory (or cytoskeletal adaptor) protein via Lys-422. This protein increases the GLYT2 internalization rate in response to PMA producing a reduction of the plasma membrane GLYT2 transporters and/or a change in GLYT2 transport activity. This could be mediated by direct GLYT2 phosphorylation on residues other than Thr-419 or Ser-420, or by phosphorylation of a regulatory protein. The removal of the positive charge and, more dramatically, the introduction of a negative charge in position 422 displaces the binding of GLYT2 to the regulatory protein making the transporter resistant to PMA. This displacement could also hamper the recognition of GLYT2 for the nonregulated internalization machinery yielding an increase of GLYT2 molecules at the plasma membrane in K422E mutant. If the negative charge is present in Thr-419 or Ser-420, the phenotype is attenuated, perhaps due to the higher distance of the negative charge to the site of interaction with the regulatory protein that is Lys-422. For this reason, in T419E mutant, the interaction GLYT2-regulatory protein can still take place but is weaker than in wild type although stronger than in S420E, generating these graded phenotypes. Therefore, we propose that T419E and S420E phenotypes are not produced through phosphorylation at position 419 or 420 but are due to the influence of the introduced negative charge on the regulatory binding site, which is Lys-422. To confirm this question, a phosphorylation study under PKC stimulation conditions will be undertaken.
An interesting question that remains open is the relationship between GLYT2 conformational alteration and PMA-induced regulation. It is evident from our results that the same residues, which are crucial for keeping the intramolecular interactions that permit the conformational changes during the transport cycle, are responsible for the PMA-induced regulation of this glycine transporter as well. Although it seems reasonable to think that the acquisition of a specific conformation is a prerequisite for the transporter internalization, in the present study we did not detect any conformational change promoted by PMA, and from our results, PMA seems not to affect the conformational state of the IL2 mutants (Fig. 6 ). On the other hand, PMA insensitivity might be a consequence of the displacement of the putative regulatory protein bound to Lys-422, and this latter event might trigger the conformational reversion. Future research will probably solve those issues.
